NCT06629376 Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia Status RECRUITING Phase PHASE1
NCT06622603 the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More Status RECRUITING Phase PHASE4
NCT06501534 A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects Status COMPLETED Phase PHASE2
NCT06439602 Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) Status COMPLETED Phase PHASE3
NCT06298071 A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout. Status RECRUITING Phase PHASE1
NCT06276556 Extension Study of ABP-671 in Participants With Gout Status TERMINATED Phase PHASE2/PHASE3
NCT06258213 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT06235710 Prevalence of Musculoskeletal Complaints in Nursing Home Residents Status COMPLETED Phase N/A
NCT06229145 A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout Status COMPLETED Phase PHASE4
NCT06189404 Effect of Tigulixostat on the Pharmacokinetics of Theophylline Status COMPLETED Phase PHASE1
NCT06056570 Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia Status COMPLETED Phase PHASE1/PHASE2
NCT05936281 A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202) Status COMPLETED Phase PHASE2
NCT05927688 Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments Status RECRUITING Phase N/A
NCT05818085 Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout Status COMPLETED Phase PHASE2/PHASE3
NCT05815901 A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients Status COMPLETED Phase PHASE3
NCT05745727 A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels Status COMPLETED Phase PHASE1